Therapeutics 2000 Inc.
This article was originally published in Start Up
Executive Summary
Drug Delivery; Pulmonary. Therapeutics 2000 has a patented liposomal aerosol mist of 1-3 microns in diameter which encapsulates drugs for deep lung delivery. The company is initially developing the technology for diseases requiring local delivery to the lungs (asthma, fungal respiratory infections) but in the future will make use of the alveolar epithelium's ability to pass molecules into the blood stream to deliver systemic drugs.